AD risk genes are also enriched in MAPK signaling pathway, which contributes to the AD pathogenesis through multiple mechanisms, including the regulation of neuronal apoptosis and phosphorylation of APP and tau47. This evidence concerns the gene APP and Alzheimer disease.